breast ultrasound News
-
AI used to catch cancer in patients with cancelled appointments
An artificial intelligence (AI)-based breast ultrasound software from Koios Medical, Inc. proven to significantly enhance the accuracy and consistency of lesion assessment for physicians across a wide range of experience levels, per a study recently published in the American Journal of Roentgenology, is now being used to diagnose breast cancer earlier for patients with appointments cancelled due ...
-
QView Medical Inc. Announces FDA PMA Approval for QVCAD for the GE Invenia 3D Automated Breast Ultrasound System (“ABUS”)
QView Medical is pleased to announce FDA approval for QVCAD to be used with the GE Invenia™ ABUS in breast screening for asymptomatic dense breasted women whose mammogram was negative. QVCAD is the next generation CAD system for automated breast ultrasound ("ABUS") based on deep learning algorithms. The QVCAD innovative C-Thru technology combined with ABUS has demonstrated a 33% improved ...
-
QView Medical Signs European Distribution Agreement to sell AI/QVCAD for Breast Cancer Detection
QView Medical and Traf Intercontinental announce a distribution agreement under which Traf International will sell QView Medical's QVCAD System to breast imaging clinics in Europe. QVCAD is the AI solution to assist the radiologist in detecting breast cancer in 3D Automated Breast Ultrasound images In this post-CoVid-19 environment, QView Medical searched for a more direct sales focus in ...
-
Breast imaging products help with coronavirus backlog
With the COVID-19 pandemic pushing breast cancer screening to the back burner for many patients, scanner and software manufacturers have more reason than ever to bring products to the market that make scans faster and more comfortable, and helping radiologists manage their growing worklists. Here’s a look at what’s new in the last year from more than a dozen companies. Koios Medical, ...
-
Hologic Adds 3D Breast Ultrasound Imaging to SuperSonic™ MACH™ 40 System
MARLBOROUGH, Mass. December 17, 2020 – Hologic, Inc. (Nasdaq: HOLX) announced today 3D ultrasound imaging is now available on the SuperSonic™ MACH™ 40 ultrasound system*. Clinicians can now access high-resolution B-mode and ShearWave™ PLUS elastography 3D volumes, which are designed to enhance diagnostic certainty. ...
-
QView Medical maintains leadership position in AI-powered breast cancer screening technology through alliance with GE Healthcare
QView Medical, a breast cancer detection pioneer and maker of the FDA-approved artificial intelligence (AI) software system for breast cancer screening, and GE Healthcare today announced that QView's QVCAD software can be launched on GE Healthcare's Invenia™ ABUS 2.0 (Automated Breast Ultrasound), which has an open platform technology that allows the integration of third-party AI tools for ...
-
New Findings Show AI Software Improves Breast Cancer Detection and Physician Accuracy
A New York City based large volume private practice radiology group conducted a quality assurance review that included an 18 month software evaluation in the breast center comprised of nine (9) specialist radiologists using an FDA cleared artificial intelligence software by Koios Medical, Inc as a second opinion for analyzing and assessing lesions found during breast ultrasound examinations. ...
-
QView Medical in Support of Breast Cancer Awareness Month Joins the Initiative of AmIDense.com
QView Medical is the only FDA AI Ultrasound Technology approved for breast screening. But now, we are moving beyond the clinical suite. QView is joining women in the initiative around Breast Cancer with the launch of AmIDense.com and the supporting #AmIDense. Let's START the conversation around Breast Density. The 2021 American Cancer Society's estimate is 280,000 women will be diagnosed with ...
-
SIIM 2020: AI nearly halves breast ultrasound reading time
Using artificial intelligence (AI) to analyze breast ultrasound lesions reduced interpretation time by 49% at a healthcare center in Missouri. The software is particularly helpful for lesions classified as BI-RADS 2, 3, and 4A, attendees of the Society for Imaging Informatics in Medicine’s (SIIM) virtual meeting learned on June 24. For almost a year, the women’s imaging department at ...
-
Poster Presentation at RSNA Compares Seno Medical’s OA/US Breast Imaging with AI Decision Support to Ultrasound Alone; Finds Significantly Better Specificity to Support Clinical Decision Making Conf
A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s Imagio opto-acoustic ultrasound (OA/US) breast imaging provides significantly better specificity than ultrasound alone. The poster, “Performance of Optoacoustic Ultrasound with an Artificial Intelligence-based Decision Support Tool vs ...
-
Seno Medical’s Imagio Breast Imaging System Named Science and Medical Category Finalist in 2022 Edison Awards Program
Seno Medical’s Imagio Breast Imaging System has been named a finalist in the 2022 Edison Awards competition in the Science and Medical category and Diagnostics sub-category. The Edison Awards program is an annual competition honoring excellence in new product and service development, marketing, human-centered design, and innovation. Past winners have included Fortune 500s, small start-ups, ...
-
Seno Medical and “Know Your Lemons” Team Up For Breast Cancer Education
Seno Medical Instruments, Inc. (Seno Medical), a Texas-based medical imaging company developing breakthrough breast cancer diagnostic technology, announced an educational partnership supporting Worldwide Breast Cancer’s “Know Your Lemons” campaign starting with the Netherlands, which has one of the highest breast cancer incidence rates in the world. Through the partnership with ...
-
Scion Co-Sponsors Cassi II Breast Biopsy Device Ultrasound Training for Chinese Physicians
During the week of Monday, April 30 – Saturday, May 5, 2012, seven physicians from China will train with internationally distinguished interventional radiologist Ken Tomkovich, MD, director of breast imaging and interventional radiology at CentraState Medical Center and affiliated with Freehold Radiology Group. The training will cover the latest imaging and interventional radiology ...
-
Seno Medical Launches CONFIDENCE Registry Study for Imagio® Breast Imaging System
Texas-based Seno Medical Instruments, Inc. (Seno) has launched its CONFIDENCE registry to evaluate the efficacy of imaging with opto-acoustic/ultrasound (OA/US) to diagnose breast abnormalities including cancer using its groundbreaking Imagio® Breast Imaging System. Approximately twelve sites will participate in the international registry, with a target of over 600 total patients ...
-
Multiple Publications and Presentations Underscore Seno Medical’s Value Proposition in Mitigating the Cost and Burden of Unnecessary Breast Biopsies
Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data publications and presentations that demonstrate the clinical utility and healthcare economic benefits of its proprietary, cutting-edge technology. ...
-
FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology
The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments, Inc. (Seno) premarket approval (PMA) for its groundbreaking diagnostic breast cancer imaging technology that helps physicians better differentiate between benign and malignant breast lesions. The company’s Imagio® Breast Imaging System ...
-
Koios Medical RSNA Live Sessions
Interested in learning more about Koios Medical during RSNA 2020? Drop in to one of our virtual sessions, or schedule a one-on-one demo here. Choose between a Koios Medical general overview of AI for Ultrasound, Koios DS Breast, Koios DS Thyroid, Workflow & Deployment, or Cocktails with Koios. Click the image below to view the schedule. To add an event to your calendar, simply click the ...
-
Breast Surgeon Known for Devotion to Patients Describes Her Strategy to Improve Their Lives
Dr. Rabia Z. Bhatti with the AMITA Resurrection Medical Center has always had a strong interest in the art of surgery. “I actually love the way that patients recover,” she explained. “There’s a gratification behind treating patients and watching them get better. And after practicing general surgery for 15 years, I realized I could provide even better care to my patients by ...
-
Scion Acquires Soft Tissue Marker with FDA Marketing Clearance from Kent Medical Devices, Inc.
June 26, 2012 – Newton, Massachusetts. Scion Medical Technologies, LLC (Scion), a company that manufactures and sells products in the general surgery area, announced today that it has acquired a soft tissue marker product line with FDA marketing clearance from Kent Medical Devices, Inc. of Minneapolis, Minnesota. “The Kent Medical Devices soft tissue marker product line bolsters our ...
-
Icecure Medical announces new independent data published in the journal of cancer therapy showing that percutaneous Cryoablation presents a potential substitute for lumpectomy for tumors <15mm using Prosense
IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, today announced that a peer reviewed article titled, “VAB and MRI Following Percutaneous Ultra-Sound Guided Cryoablation for Primary Early-Stage Breast Cancer: A Pilot Study in ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you